Renpeng Zhou
Hefei, 230601, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
AdipoRon ameliorates synovial inflammatory lesions and joint destruction in experimental arthritis by downregulating KRT7.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: June 23, 2026
HDAC1-mediated PKM2 delactylation modification regulates CIRP-induced angiogenesis in rheumatoid arthritis.
Journal: Biochemical pharmacology
Published: May 08, 2026
Virtual bioequivalence-guided PBBM prediction for ibuprofen/diphenhydramine citrate tablets: impact of dissolution variability and clinical standard development.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: January 30, 2026
TRPM7 inhibition alleviates acute gouty arthritis in mice by suppressing M1 polarization through the EDN1/EDNRB axis.
Journal: International immunopharmacology
Published: January 16, 2026
The Kv1.3 blocker PAP‑1 alleviates psoriasis‑like dermatitis in rats via suppressing inflammation and angiogenesis.
Journal: Communications biology
Published: September 30, 2025
Phase I randomized double-blind parallel-group study: pharmacokinetics, safety, and immunogenicity of pertuzumab biosimilar SYSA1901 in healthy Chinese males.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: September 03, 2025
G3BP2 facilitates abnormal activation of fibroblast-like synoviocytes through p53 signaling pathway in rheumatoid arthritis.
Journal: International immunopharmacology
Published: September 01, 2025
Peroxiredoxin 6: A Regulatory Target in Cellular Senescence and Age-Related Diseases.
Journal: Antioxidants & redox signaling
Published: June 11, 2025
Effects of Histone Deacetylases (HDACs) in Programmed Cell Death: Execution Mechanism and Regulatory Pathways.
Journal: Cell biology international
Published: June 07, 2025
From pathogenesis to therapeutic targeting: new insight into TAM receptors in rheumatoid arthritis.
Journal: Cell & bioscience
Published: May 29, 2025
Safety, pharmacokinetics, and efficacy of HY-072808 ointment, a novel PDE4 inhibitor, in adolescent and adult patients with mild-to-moderate AD.
Journal: Expert opinion on investigational drugs
Published: May 24, 2025
Ion channels as therapeutic targets in osteoarthritis.
Journal: Trends in pharmacological sciences
Published: April 30, 2025
Last Updated: 09/26/2026